TrialBritish journal of cancer2013

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours.

H K Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.